Author

Graham P. Allaway

Observed names: G Allaway, G P Allaway, G. P. Allaway, GRAHAM P. ALLAWAY, Graham Allaway, Graham P Allaway

Observed institutions: University of North Carolina at Chapel Hill, Niigata University of Pharmacy and Medical and Life Sciences, National Institutes of Health, Memorial University of Newfoundland, Natural Environment Research Council, Aaron Diamond AIDS Research Center, Duke University, George Washington University, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Dental and Craniofacial Research, Progenics Pharmaceuticals (United States), Duke Medical Center, National Institute of Allergy and Infectious Diseases, National Cancer Institute, Cureveda (United States), New York University, University at Buffalo, State University of New York, Niigata University

OpenAlex ID: A5081463463

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1996 · Tatjana Dragic, Virginia Litwin, et al. · Nature · 3,143

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

1996 · Alexandra Trkola, Tatjana Dragic, et al. · Nature · 1,024

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

1998 · George A. Donzella, Dominique Schols, et al. · Nature Medicine · 758

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG

1995 · A Trkola, A B Pomales, et al. · Journal of Virology · 478

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

2003 · F. Li, R. Goila-Gaur, et al. · Proceedings of the National Academy of Sciences · 418

Expression and Characterization of CD4-IgG 2 , a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

1995 · GRAHAM P. ALLAWAY, KAREN L. DAVIS-BRUNO, et al. · AIDS Research and Human Retroviruses · 230

Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry

1998 · Tatjana Dragic, Alexandra Trkola, et al. · Journal of Virology · 211

PDF

Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-O-(3′,3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection

2007 · Patrick F. Smith, Abayomi Ogundele, et al. · Antimicrobial Agents and Chemotherapy · 192

Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen.

1990 · B S Prabhakar, G P Allaway, et al. · Journal of Clinical Investigation · 98

PDF

Bevirimat: A Novel Maturation Inhibitor for the Treatment of HIV-1 Infection

2008 · David E Martin, Karl Salzwedel, et al. · Antiviral chemistry & chemotherapy · 90

Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1

2009 · Kurt Van Baelen, Karl Salzwedel, et al. · Antimicrobial Agents and Chemotherapy · 83

Anti-AIDS Agents. 78. Design, Synthesis, Metabolic Stability Assessment, and Antiviral Evaluation of Novel Betulinic Acid Derivatives as Potent Anti-Human Immunodeficiency Virus (HIV) Agents

2009 · Keduo Qian, Donglei Yu, et al. · Journal of Medicinal Chemistry · 78

Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses.

1988 · E L Oates, G P Allaway, et al. · Journal of Biological Chemistry · 78

Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral Envelope

2003 · Nicole R. Kilgore, Karl Salzwedel, et al. · Journal of Virology · 71

Determinants of activity of the HIV-1 maturation inhibitor PA-457

2006 · Feng Li, Dorian Zoumplis, et al. · Virology · 67

Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides

1991 · Osamu Takai, Rajesh K. Desai, et al. · Biochemical and Biophysical Research Communications · 66

The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV

2005 · Donglei Yu, Carl T Wild, et al. · Expert Opinion on Investigational Drugs · 51

Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice

2007 · Cheryl A. Stoddart, Pheroze Joshi, et al. · PLoS ONE · 50

PDF

Host range and virulence of five baculoviruses from lepidopterous hosts

1984 · GRAHAM P. ALLAWAY, CHRISTOPHER C. PAYNE · Annals of Applied Biology · 48

Anti-HIV Agents. Part 55: 3′R,4′R-Di-(O)-(−)-camphanoyl-2′,2′-dimethyldihydropyrano[2,3-f]chromone (DCP), a Novel Anti-HIV agent

2003 · Donglei Yu, Arnold Brossi, et al. · Bioorganic & Medicinal Chemistry Letters · 46

CD4-Immunoglobulin G2 Protects Hu-PBL-SCID Mice against Challenge by Primary Human Immunodeficiency Virus Type 1 Isolates

1998 · Marie-Claire Gauduin, Graham P. Allaway, et al. · Journal of Virology · 44

A biochemical and biological comparison of three European isolates of nuclear polyhedrosis viruses fromAgrotis segetum

1983 · G. P. Allaway, C. C. Payne · Archives of Virology · 42

Anti-AIDS Agents. 52. Synthesis and Anti-HIV Activity of Hydroxymethyl (3‘R,4‘R)-3‘,4‘-Di-O-(S)-camphanoyl-(+)-cis-khellactone Derivatives

2003 · Lan Xie, Donglei Yu, et al. · Journal of Medicinal Chemistry · 41

Characterization of the 70kDa component of the human Ku autoantigen expressed in insect cell nuclei using a recombinant baculovirus vector

1990 · Graham P. Allaway, Alfred A. Vivino, et al. · Biochemical and Biophysical Research Communications · 41

Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation

2009 · Abdul S. Yunus, Trent P. Jackson, et al. · Virology · 40

Works count: 53

Citation count: 7,867

H-index: 30

I10-index: 38